Overview consensus statement 1 1 This supplement and conference were funded by an unrestricted educational grant from AstraZeneca Pharmaceuticals. Myles A. Brown is a paid consultant to, and is a study investigator funded by, Novartis Pharmaceuticals. Daniel J. George is a paid consultant to and a member of the speakers’ bureau for Novartis Pharmaceuticals; a paid consultant to TAP Pharmaceuticals; holds stock in and is on the editorial staff for Veritas Medicine; and is a study investigator funded by Wyeth-Ayerst. William Kevin Kelly is a member of the medical advisory board for Amgen Pharmaceuticals and a member of the speakers’ bureau for AstraZeneca Pharmaceuticals and Bristol-Meyers Squibb. Laurence Klotz is a member of the speakers’ bureau for and a paid consultant to AstraZeneca Pharmaceuticals; a paid consultant to Aventis Pharmaceuticals; and a study investigator funded by Abbott Laboratories Canada. W. Robert Lee is a member of the medical advisory board for Nycomed-Amersham. Deborah P. Lubeck is a study investigator funded by TAP Pharmaceuticals. David G. McLeod is a study investigator funded by AstraZeneca Pharmaceuticals. Alan Pollack is a paid consultant to Amgen Pharmaceuticals, AstraZeneca Pharmaceuticals, and TAP Pharmaceuticals. Oliver Sartor is a paid consultant to and a member of the medical advisory board for Atrix Pharmaceuticals. Matthew R. Smith is a study investigator funded by AstraZeneca Pharmaceuticals and is a paid consultant to and a study investigator funded by Novartis Pharmaceuticals.
Titel:
Overview consensus statement 1 1 This supplement and conference were funded by an unrestricted educational grant from AstraZeneca Pharmaceuticals. Myles A. Brown is a paid consultant to, and is a study investigator funded by, Novartis Pharmaceuticals. Daniel J. George is a paid consultant to and a member of the speakers’ bureau for Novartis Pharmaceuticals; a paid consultant to TAP Pharmaceuticals; holds stock in and is on the editorial staff for Veritas Medicine; and is a study investigator funded by Wyeth-Ayerst. William Kevin Kelly is a member of the medical advisory board for Amgen Pharmaceuticals and a member of the speakers’ bureau for AstraZeneca Pharmaceuticals and Bristol-Meyers Squibb. Laurence Klotz is a member of the speakers’ bureau for and a paid consultant to AstraZeneca Pharmaceuticals; a paid consultant to Aventis Pharmaceuticals; and a study investigator funded by Abbott Laboratories Canada. W. Robert Lee is a member of the medical advisory board for Nycomed-Amersham. Deborah P. Lubeck is a study investigator funded by TAP Pharmaceuticals. David G. McLeod is a study investigator funded by AstraZeneca Pharmaceuticals. Alan Pollack is a paid consultant to Amgen Pharmaceuticals, AstraZeneca Pharmaceuticals, and TAP Pharmaceuticals. Oliver Sartor is a paid consultant to and a member of the medical advisory board for Atrix Pharmaceuticals. Matthew R. Smith is a study investigator funded by AstraZeneca Pharmaceuticals and is a paid consultant to and a study investigator funded by Novartis Pharmaceuticals.
Auteur:
Carroll, Peter R Kantoff, Philip W Balk, Steven P Brown, Myles A D’amico, Anthony V George, Daniel J Grossfeld, Gary D Johnson, Candace S Kelly, William Kevin Klotz, Laurence Lee, W.Robert Lubeck, Deborah P Mcleod, David G Oh, William K Pollack, Alan Sartor, Oliver Smith, Matthew R Hart, Carol